ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
MRI Epicenters Differentiate Spatiotemporal Patterns of Neurodegeneration in Parkinson's Disease.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Biological heterogeneity in Parkinson's disease: implications for MRI-based patient stratification.NPJ Parkinson's disease · 2026Review
- Accelerated biological aging and brain structural alterations linking air pollution to dementia risk: a prospective cohort study.The journal of nutrition, health & aging · 2026Article
- Mapping Multiscale Brain Changes in Primary Angle-Closure Glaucoma Using Regional Radiomics Similarity Networks.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Neuroimaging Epicenters as Vulnerable Nodes in Plasma p-tau217/Aβ42-Positive Alzheimer's Disease.Research (Washington, D.C.) · 2026Article
- MRI Epicenters Differentiate Spatiotemporal Patterns of Neurodegeneration in Parkinson's Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- MRI structural and functional axial asymmetry in the brain-first versus body-first subtypes of Parkinson's disease.NPJ Parkinson's disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Parkinson's disease (PD) exhibits clinical and neuropathological heterogeneity, potentially driven by distinct spatiotemporal neurodegenerative patterns. This study utilizes a connectivity-based MRI epicenter model combined with unsupervised clustering to identify unique degenerative epicenters in PD. Analyzing cross-sectional multi-modal MRI data from 278 PD patients and 177 healthy controls, this work identifies two distinct neurodegenerative epicenter patterns. Subtype 1 exhibits epicenters predominantly in cerebellar and midbrain regions associated with severe motor symptoms and rapid progression. Subtype 2 shows epicenters primarily in cortical and striatal regions with milder progression. These patterns are validated in an independent cohort of 66 PD patients and shows consistency in longitudinal follow-up. Additionally, a predictive model incorporating epicenter traits and structural connectivity properties is developed, accurately forecasting individualized neurodegenerative progression. Spatial correlation analyses further reveal overlapping epicenter distributions between PD subtype 1 and other movement disorders, including essential tremor and multiple system atrophy, suggesting potential shared pathological mechanisms. These results delineate PD heterogeneity through distinct epicenter-driven neurodegenerative trajectories, bridging the gap between neuroanatomical spread patterns and clinical variability. This novel framework not only enhances the understanding of PD's neuropathological complexity but also advances personalized prognosis and highlights connectivity-based epicenters as promising biomarkers for PD subtyping and therapeutic targeting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.